Harteraad & Hartstichting: Merger Announced for 2025
Dutch Heart Foundation and harteraad Merge to Strengthen Cardiovascular Care in the Netherlands
Table of Contents
As of August 14, 2025, a significant growth in Dutch healthcare sees harteraad and the Hartstichting (Dutch Heart Foundation) officially merging. This union, years in the making, aims to provide enhanced care and improve the lives of individuals affected by cardiovascular disease, while fostering a healthier future for the entire nation.
Addressing the Growing Challenge of Cardiovascular Disease
Currently, 1.7 million people in the Netherlands are living wiht some form of heart or vascular disease. Projections indicate a concerning rise to 2.6 million by 2030 if preventative measures and improved treatments are not implemented. The merger between Harteraad and the Hartstichting represents a proactive step towards tackling this growing health challenge. By combining their strengths, the newly formed institution seeks to bolster prevention efforts, advance treatment options, and provide more comprehensive support to patients and their families. This unified front will also amplify their voice when advocating for patient interests with the government and within the healthcare sector.
Combining Expertise and Resources for Greater Impact
The merger strategically combines the knowledge, resources, and extensive networks of both Harteraad and the Hartstichting. This integration encompasses critical areas such as research, prevention programs, data analysis, and advocacy initiatives. By streamlining these functions, the organization aims to facilitate more effective collaboration between healthcare professionals, patients, and their loved ones, all working towards a heart-healthy Netherlands.Hans Snijder, Director-Director of the hartstichting, emphasizes the importance of patient advocacy, stating, “Together we can give patients a voice more actively, because thay are our most important ambassadors.” Gerdy Schippers,Chairman of Harteraad,adds,”In everything we do together,we focus on making their lives more bearable and on reducing the planned growth in the number of patients. That is of great social importance.”
A Phased Approach to Integration
The merger is being implemented in a phased manner to ensure a smooth transition. This involves carefully integrating the teams, systems, and processes of both organizations. Throughout each step, colleagues, volunteers, patients, and partners will be actively involved to ensure their perspectives are considered. While both organizations will initially retain their individual names, the merged entity will operate solely under the name Hartstichting starting in January 2026.
Looking Ahead: A Stronger Future for Cardiovascular Health
The merger of Harteraad and the Hartstichting marks a pivotal moment for cardiovascular care in the Netherlands. By uniting their expertise and resources, the new Hartstichting is poised to make significant strides in prevention, treatment, and patient support. This collaborative approach not only addresses the immediate challenges posed by cardiovascular disease but also lays the foundation for a healthier future for generations to come, positioning the Netherlands as a leader in proactive cardiovascular health management.